Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Oct
31
Redefining Hidradenitis Suppurativa (HS) Care Through Community and Collaboration
Oct
31
BIMZELX® (bimekizumab-bkzx) Data in Hidradenitis Suppurativa Showed Improvements in Pain and Resolution of Draining Tunnels Sustained to Three Years
Oct
29
UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
Oct
29
UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
Oct
27
Generalized myasthenia gravis management with shared decision-making
Oct
25
BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
Oct
23
Multidisciplinary Collaboration as the Future of Patient-Centered Care
Oct
14
Innovative Collaborations: Enhancing Epilepsy Care through UCB and Morehouse's Community-Based Approach
Oct
14
Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior